Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 233

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 233
---
 in the first quarter of fiscal year 2025. |

| (4) | Amount includes: For Dr. Itri, reimbursement for monthly housing expenses and payment of consulting fees                                                                                                                                       
 pursuant to a consulting agreement entered into Dr. Itri and the Company, effective as of October 1, 2024; for Drs. Itri and Desai, payment of severance payments and payment of accrued paid time off in connection with their termination of 
 employment with the Company; for Dr. Desai, $10,000 received as a retainer fee for service commencing on October 1, 2024 as a non-employee member of the Aadi board of directors pursuant to the                                               
 Outside Director Compensation Policy.                                                                                                                                                                                                          |

| (5) | Dr. Lennon joined the Company in October 2023 as our President and Chief Executive Officer and a member of 
 our board of directors.                                                                                    |

| (6) | Mr. Giacobello has served as our Chief Financial Officer since joining the Company in November 2021. From 
 March 14, 2023 to October 2, 2023, he also served as our interim President and Chief Executive Officer.   |

| (7) | Mr. Ball has served as our Chief Technical Operations Officer since March 2024 and served as our Chief 
 Quality Officer and Senior Vice President, Manufacturing Operations from August 2022 to March 2024.    |

| (8) | Dr. Desai served as our Executive Chairman until October 1, 2024. |

| (9) | Dr. Itri served as our Chief Medical Officer until October 1, 2024, following which Dr. Itri and                                                                                                                                                  
 the Company entered into a consulting agreement pursuant to which Dr. Itri will provide 10 hours of consulting and advisory services to the Company per month in exchange for a monthly retainer of $8,000 for an initial term of 3 months, which 
 term may be renewed for subsequent 3 month periods.                                                                                                                                                                                               |

- 162 -

Outstanding Equity Awards at December 31, 2024 The following table sets forth information regarding outstanding equity awards for each of the named executive officers as of December 31, 2024.

|                                    |     | Option Awards |            |    |     |             |         |     |               |         |     |          |       |     |            |            |     | Stock Awards      |        |     |                 |         |